Type 17 CD8+ T cells display enhanced antitumor immunity.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Blood

• Publication date

  2009-07-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood-2009-02-203935PMID 19471017PMCID PMC2713473
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cutting Edge: Phenotypic Characterization and Differentiation of Human CD8+ T Cells Producing IL-171

  2009cited by this paper
• IL-21 Mediates Suppressive Effects via Its Induction of IL-101

  2009cited by this paper
• The clone ranger?

  2008cited by this paper
• Cutting edge: IFN-gamma enables APC to promote memory Th17 and abate Th1 cell development.

  2008cited by this paper
• IL-6–dependent spontaneous proliferation is required for the induction of colitogenic IL-17–producing CD8+ T cells

  2008cited by this paper
• IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy.

  2008cited by this paper
• Tumor-specific Th17-polarized cells eradicate large established melanoma.

  2008cited by this paper
• Anomalous Type 17 Response to Viral Infection by CD8+ T Cells Lacking T-bet and Eomesodermin

  2008cited by this paper
• Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

  2008cited by this paper
• Cutting Edge: IFN-γ Enables APC to Promote Memory Th17 and Abate Th1 Cell Development1

  2008cited by this paper
• Th17 and cancer: friends or foes?

  2008cited by this paper
• Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer.

  2007cited by this paper
• Development, cytokine profile and function of human interleukin 17–producing helper T cells

  2007cited by this paper
• Induction of a distinct CD8 Tnc17 subset by transforming growth factor‐β and interleukin‐6

  2007cited by this paper
• Less Yin, More Yang: Confronting the Barriers to Cancer Immunotherapy

  2007cited by this paper
• Principles of adoptive T cell cancer therapy.

  2007cited by this paper
• Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes

  2006cited by this paper
• Programming CD8+ T cells for effective immunotherapy.

  2006cited by this paper
• The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.

  2006cited by this paper
• Prospects and limitations of T cell receptor gene therapy.

  2005cited by this paper
• Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

  2005cited by this paper
• Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin

  2005cited by this paper
• Prospects and limitations of T cell receptor gene therapy.

  2005cited by this paper
• Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells.

  2005cited by this paper
• Control of Effector CD8+ T Cell Function by the Transcription Factor Eomesodermin

  2003cited by this paper
• Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8+ T Cells

  2003cited by this paper
• The clone ranger.

  1978cited by this paper

• Microbiota-Derived Proteins Shape T Cell Responses in Healthy and Colorectal Cancer Subjects

  2026cites this paper
• Clonal sharing of CD8+ T-cells links skin and joint inflammation in psoriatic arthritis

  2025cites this paper
• Effector Tc17 cells resist shift from OXPHOS to aerobic glycolysis

  2025cites this paper
• A Novel RORγ-Selective Agonist Facilitates the Infiltration of Effector T Cells and Innate Immune Cells into Tumor Tissue, Demonstrating Antitumor Efficacy.

  2025cites this paper
• Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments

  2025cites this paper
• An mRNA lipid nanoparticle-incorporated nanofiber-hydrogel composite for cancer immunotherapy

  2025cites this paper
• Cell-cell fusion and immunostimulatory cytokines significantly impact oncolytic vaccinia virus immunotherapeutic potential.

  2025cites this paper
• Targeting YAP1 to improve the efficacy of immune checkpoint inhibitors in liver cancer: mechanism and strategy

  2024cites this paper
• Discovery of Biaryl Amide Derivatives as Potent, Selective, and Orally Bioavailable RORγt Agonists for Cancer Immunotherapy.

  2023cites this paper
• PD-1 limits differentiation and plasticity of Tc17 cells

  2023cites this paper
• Friend or Foe – Tc17 cell generation and current evidence for their importance in human disease

  2023cites this paper
• Designing multi-epitope vaccine against important colorectal cancer (CRC) associated pathogens based on immunoinformatics approach

  2023cites this paper
• Human in vitro-induced IL-17A+ CD8+ T-cells exert pro-inflammatory effects on synovial fibroblasts

  2023cites this paper
• Phenotypic, molecular and functional characterisation of human in vitro-generated IL-17A+ CD8+ T-cells

  2022cites this paper
• Adoptive transfer of IL‐4 reprogrammed Tc17 cells elicits anti‐tumour immunity through functional plasticity

  2022cites this paper
• The role of Th17 cells in chronic lymphocytic leukemia: friend or foe?

  2022cites this paper
• Cancer-inducing niche: the force of chronic inflammation

  2022cites this paper
• RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers

  2022cites this paper
• Substituted Diaryl Ether Compounds as Retinoic Acid-Related Orphan Receptor-γt (RORγt) Agonists.

  2021cites this paper
• The interplay of obesity, gut microbiome and diet in the immune check point inhibitors therapy era.

  2021cites this paper
• Discovery of 2-(Ortho-Substituted Benzyl)-Indole Derivatives as Potent and Orally Bioavailable RORγ Agonists with Antitumor Activity.

  2021cites this paper
• Interleukin (IL)-9 Supports the Tumor-Promoting Environment of Chronic Lymphocytic Leukemia

  2021cites this paper
• New Insights on CD8+ T Cells in Inflammatory Bowel Disease and Therapeutic Approaches

  2021cites this paper
• CpG Oligodeoxynucleotides for Anticancer Monotherapy from Preclinical Stages to Clinical Trials

  2021cites this paper
• Induction of Unique STAT Heterodimers by IL-21 Provokes IL-1RI Expression on CD8+ T Cells, Resulting in Enhanced IL-1β Dependent Effector Function

  2021cites this paper
• Role of Cytokines in Tumor Immunity and Immune Tolerance to Cancer

  2020cites this paper
• Human NK cells prime inflammatory DC precursors to induce Tc17 differentiation.

  2020cites this paper
• Comprehensive Analysis of Immunoinhibitors Identifies LGALS9 and TGFBR1 as Potential Prognostic Biomarkers for Pancreatic Cancer

  2020cites this paper
• Mycobacterium smegmatis Vaccine Vector Elicits CD4+ Th17 and CD8+ Tc17 T Cells With Therapeutic Potential to Infections With Mycobacterium avium

  2020cites this paper
• Tumor-infiltrating IL-17A+ cells determine favorable prognosis and adjuvant chemotherapeutic response in muscle-invasive bladder cancer

  2020cites this paper
• The Roles of CD8+ T Cell Subsets in Antitumor Immunity.

  2020cites this paper
• IL-9 and IL-9-producing cells in tumor immunity

  2020cites this paper
• Role of Dendritic Epidermal T Cells in Cutaneous Carcinoma

  2020cites this paper
• IL-17-Producing Cells in Tumor Immunity: Friends or Foes?

  2020cites this paper
• Substituted benzyloxytricyclic compounds as retinoic acid-related orphan receptor gamma t (RORγt) agonists.

  2020cites this paper
• Regulatory T-Cells and Th17 Cells in Tumor Microenvironment

  2020cites this paper
• Multifunctional T cell response in convalescent patients two years after ZIKV infection

  2020cites this paper
• Comprehensive Phenotyping of Peripheral Blood T Lymphocytes in Healthy Mice

  2020cites this paper
• Polyfunctional, Proinflammatory, Tissue‐Resident Memory Phenotype and Function of Synovial Interleukin‐17A+CD8+ T Cells in Psoriatic Arthritis

  2020cites this paper
• IL6 Induces an IL22+ CD8+ T-cell Subset with Potent Antitumor Function

  2020cites this paper
• Discovery of tetrahydroquinolines and benzomorpholines as novel potent RORγt agonists.

  2020cites this paper
• Tc17 biology and function: Novel concepts.

  2020cites this paper
• RORγ Agonists Enhance the Sustained Antitumor Activity through Intrinsic Tc17 Cytotoxicity and Tc1 Recruitment

  2019cites this paper
• Long‐term prognostic significance of interleukin‐17‐producing T cells in patients with non‐small cell lung cancer

  2019cites this paper
• Targeting the interleukin-17 immune axis for cancer immunotherapy

  2019cites this paper
• Phase 1 Open-Label, Multicenter Study of First-in-Class RORγ Agonist LYC-55716 (Cintirorgon): Safety, Tolerability, and Preliminary Evidence of Antitumor Activity

  2019cites this paper
• IL17A Blockade Successfully Treated Psoriasiform Dermatologic Toxicity from Immunotherapy

  2019cites this paper
• Positive effect of RORγt on the prognosis of thyroid papillary carcinoma patients combined with Hashimoto's thyroiditis.

  2018cites this paper
• Killed Propionibacterium acnes enhances immunogenicity and tumor growth control of a dendritic-tumor cell hybrid vaccine in a murine melanoma model

  2018cites this paper
• The Secrets of T Cell Polarization

  2018cites this paper
• In Vitro-Generated Tc17 Cells Present a Memory Phenotype and Serve As a Reservoir of Tc1 Cells In Vivo

  2018cites this paper
• Cholesterol negatively regulates IL-9–producing CD8+ T cell differentiation and antitumor activity

  2018cites this paper
• IL-17A Is Critical for CD8+ T Effector Response in Airway Epithelial Injury After Transplantation

  2018cites this paper
• In Vitro Priming of Adoptively Transferred T Cells with a RORγ Agonist Confers Durable Memory and Stemness In Vivo.

  2018cites this paper
• T cells in solid tumors : investigating the immunomodulation in the tumor microenvironment

  2018cites this paper
• Retinoic Acid Receptor-Related Orphan Receptor γt (RORγt) Agonists as Potential Small Molecule Therapeutics for Cancer Immunotherapy.

  2018cites this paper
• Chimeric Antigen Receptor

  2018cites this paper
• Combination epidermal growth factor receptor variant III peptide-pulsed dendritic cell vaccine with miR-326 results in enhanced killing on EGFRvIII-positive cells

  2017cites this paper
• Initiative action of tumor-associated macrophage during tumor metastasis

  2017cites this paper
• The differentiation and plasticity of Tc17 cells are regulated by CTLA-4-mediated effects on STATs

  2017cites this paper
• The dichotomy of T helper 17 cells in cancer

  2017cites this paper
• Tc 17 CD 8 T Cells : Functional Plasticity and Subset Diversity 1

  2017cites this paper
• Pathogenic Role of IL-17-Producing Immune Cells in Obesity, and Related Inflammatory Diseases

  2017cites this paper
• Expression of IL-23/Th17-related cytokines in basal cell carcinoma and in the response to medical treatments

  2017cites this paper
• Variation of IL-17A and IL-17F Genes in Patients with Breast Cancer in a Population from Southern IRAN

  2016cites this paper
• Chemokines, cytokines and exosomes help tumors to shape inflammatory microenvironment.

  2016cites this paper
• IL-17+ CD8+ T cells: Differentiation, phenotype and role in inflammatory disease

  2016cites this paper
• Adaptive immunity in the liver

  2016cites this paper
• L-17+ CD8+ T cells: Differentiation, phenotype and role in nflammatory disease

  2016cites this paper
• IL-17A produced by peritoneal macrophages promote the accumulation and function of granulocytic myeloid-derived suppressor cells in the development of colitis-associated cancer

  2016cites this paper
• TGF-β and IL-21 cooperatively stimulate activated CD8(+) T cells to differentiate into Tc17 cells.

  2016cites this paper
• Children diagnosed with both Type 1 diabetes and Celiac disease - An Immunological challenge

  2016cites this paper
• Synthetic RORγ agonists regulate multiple pathways to enhance antitumor immunity

  2016cites this paper
• Circulating Tumor Cells (CTC) Are Associated with Defects in Adaptive Immunity in Patients with Inflammatory Breast Cancer

  2016cites this paper
• CD8+ T Lymphocyte Subsets in Bladder Tumor Draining Lymph Nodes.

  2016cites this paper
• Tc17 cells are a proinflammatory, plastic lineage of pathogenic CD8+ T cells that induce GVHD without antileukemic effects.

  2015cites this paper
• Dendritic Cells in Irradiated Mice Trigger the Functional Plasticity and Antitumor Activity of Adoptively Transferred Tc17 Cells via IL12 Signaling

  2015cites this paper
• SUMO2 overexpression enhances the generation and function of interleukin-17-producing CD8⁺ T cells in mice.

  2015cites this paper
• Chimeric Antigen Receptor– and TCR-Modified T Cells Enter Main Street and Wall Street

  2015cites this paper
• CD73‐mediated adenosine production promotes stem cell‐like properties in mouse Tc17 cells

  2015cites this paper
• Regulation of T Cell Death in Alloimmune-Mediated Vascular Rejection

  2015cites this paper
• The Inducible Costimulator Augments Tc17 Cell Responses to Self and Tumor Tissue

  2015influential citation
• Deficiency of IL-17A, but not the prototypical Th17 transcription factor RORγt, decreases murine spontaneous intestinal tumorigenesis

  2015cites this paper
• Targeting of HPV-16+ Epithelial Cancer Cells by TCR Gene Engineered T Cells Directed against E6

  2015cites this paper
• Interleukin-17 levels correlate with poor prognosis and vascular endothelial growth factor concentration in the serum of patients with non-small cell lung cancer

  2015cites this paper
• Novel immunotherapies for hematologic malignancies

  2015cites this paper
• Smart CARs engineered for cancer immunotherapy

  2015cites this paper
• Regulatory T Cells and Th17 Cells in Cancer Microenvironment

  2015cites this paper
• Quality of CTL Therapies: A Changing Landscape

  2015cites this paper
• Étude de la différenciation des lymphocytes T CD8+ effecteurs et mémoires : rôle de la cellule présentatrice d’antigène et de la voie de signalisation Notch

  2015cites this paper
• Cell Responses to Self and Tumor Tissue The Inducible Costimulator Augments Tc17

  2015influential citation
• Immunobiology of IL-17A in human colorectal cancer

  2015cites this paper
• Comorbid Development of Infection and Cancer

  2015cites this paper
• IL-17A-producing T cells and associated cytokines are involved in the progression of gastric cancer.

  2015cites this paper
• Current status of IL-10 and regulatory T-cells in cancer

  2015cites this paper
• Interleukin-17 and type 17 helper T cells in cancer management and research

  2014cites this paper
• Regression of established renal cell carcinoma in nude mice using lentivirus-transduced human T cells expressing a human anti-CAIX chimeric antigen receptor

  2014cites this paper
• Microenvironment and Immunology IL-17 A Produced by gd T Cells Promotes Tumor Growth in Hepatocellular Carcinoma

  2014cites this paper
• Immune Control in Hepatocellular Carcinoma Development and Progression: Role of Stromal Cells

  2014cites this paper
• IRF4 at the crossroads of effector T‐cell fate decision

  2014cites this paper